Managements of locally advanced unresectable thymic epithelial tumors

Chen Sung Lin, Kuang T. Kuo, Wen H. Hsu, Biing Shiun Huang, Yu Chung Wu, Han Shui Hsu, Min Hsiung Huang, Liang Shun Wang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background. Surgery is the treatment of choice for thymic epithelial tumors (TET), but the resectability is about 60-70%. For those with locally advanced unresectable TETs (LAU-TETs), some controversies about the prognostic factors and treatment modalities existed. The aims of this study are to elucidate the roles of various therapeutic options and to determine the survival and prognostic factors of LAU-TETs. Methods. Twenty-seven patients diagnosed with LAU-TETs underwent treatment in Taipei Veterans General Hospital between 1979 and 1997. Multiple treatment modalities, including surgical intervention, irradiation and chemotherapy, were advocated for these patients. The clinicopathological factors and the effects of the treatment modalities were evaluated retrospectively. Results. Twenty seven cases of LAU-TETs, included 18 thymomas (12 at stage III and 6 at stage IVa) and 9 thymic carcinomas (4 at stage III and 5 at stage IVa), were enrolled for study. The overall 5-year and 10-year survival rates were 54.6% and 35.1%, respectively. Patients receiving debulking surgery and those with irradiation dosage higher than 4400 cGy had significantly better survivals (P = 0.021 and P = 0.016, respectively). Conclusions. Aggressive debulking surgery and sufficient irradiation dosage provide better survivals for patients with LAU-TETs, especially for those with thymoma.

Original languageEnglish
Pages (from-to)172-178
Number of pages7
JournalJournal of the Chinese Medical Association
Volume67
Issue number4
Publication statusPublished - Apr 2004
Externally publishedYes

Fingerprint

Thymoma
Survival
Therapeutics
Veterans Hospitals
General Hospitals
Thymic epithelial tumor
Survival Rate
Drug Therapy

Keywords

  • Chemotherapy
  • Irradiation
  • Surgery
  • Thymic carcinoma
  • Thymoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lin, C. S., Kuo, K. T., Hsu, W. H., Huang, B. S., Wu, Y. C., Hsu, H. S., ... Wang, L. S. (2004). Managements of locally advanced unresectable thymic epithelial tumors. Journal of the Chinese Medical Association, 67(4), 172-178.

Managements of locally advanced unresectable thymic epithelial tumors. / Lin, Chen Sung; Kuo, Kuang T.; Hsu, Wen H.; Huang, Biing Shiun; Wu, Yu Chung; Hsu, Han Shui; Huang, Min Hsiung; Wang, Liang Shun.

In: Journal of the Chinese Medical Association, Vol. 67, No. 4, 04.2004, p. 172-178.

Research output: Contribution to journalArticle

Lin, CS, Kuo, KT, Hsu, WH, Huang, BS, Wu, YC, Hsu, HS, Huang, MH & Wang, LS 2004, 'Managements of locally advanced unresectable thymic epithelial tumors', Journal of the Chinese Medical Association, vol. 67, no. 4, pp. 172-178.
Lin, Chen Sung ; Kuo, Kuang T. ; Hsu, Wen H. ; Huang, Biing Shiun ; Wu, Yu Chung ; Hsu, Han Shui ; Huang, Min Hsiung ; Wang, Liang Shun. / Managements of locally advanced unresectable thymic epithelial tumors. In: Journal of the Chinese Medical Association. 2004 ; Vol. 67, No. 4. pp. 172-178.
@article{5a4fc714b4ac4d54b8695f997f70634c,
title = "Managements of locally advanced unresectable thymic epithelial tumors",
abstract = "Background. Surgery is the treatment of choice for thymic epithelial tumors (TET), but the resectability is about 60-70{\%}. For those with locally advanced unresectable TETs (LAU-TETs), some controversies about the prognostic factors and treatment modalities existed. The aims of this study are to elucidate the roles of various therapeutic options and to determine the survival and prognostic factors of LAU-TETs. Methods. Twenty-seven patients diagnosed with LAU-TETs underwent treatment in Taipei Veterans General Hospital between 1979 and 1997. Multiple treatment modalities, including surgical intervention, irradiation and chemotherapy, were advocated for these patients. The clinicopathological factors and the effects of the treatment modalities were evaluated retrospectively. Results. Twenty seven cases of LAU-TETs, included 18 thymomas (12 at stage III and 6 at stage IVa) and 9 thymic carcinomas (4 at stage III and 5 at stage IVa), were enrolled for study. The overall 5-year and 10-year survival rates were 54.6{\%} and 35.1{\%}, respectively. Patients receiving debulking surgery and those with irradiation dosage higher than 4400 cGy had significantly better survivals (P = 0.021 and P = 0.016, respectively). Conclusions. Aggressive debulking surgery and sufficient irradiation dosage provide better survivals for patients with LAU-TETs, especially for those with thymoma.",
keywords = "Chemotherapy, Irradiation, Surgery, Thymic carcinoma, Thymoma",
author = "Lin, {Chen Sung} and Kuo, {Kuang T.} and Hsu, {Wen H.} and Huang, {Biing Shiun} and Wu, {Yu Chung} and Hsu, {Han Shui} and Huang, {Min Hsiung} and Wang, {Liang Shun}",
year = "2004",
month = "4",
language = "English",
volume = "67",
pages = "172--178",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - Managements of locally advanced unresectable thymic epithelial tumors

AU - Lin, Chen Sung

AU - Kuo, Kuang T.

AU - Hsu, Wen H.

AU - Huang, Biing Shiun

AU - Wu, Yu Chung

AU - Hsu, Han Shui

AU - Huang, Min Hsiung

AU - Wang, Liang Shun

PY - 2004/4

Y1 - 2004/4

N2 - Background. Surgery is the treatment of choice for thymic epithelial tumors (TET), but the resectability is about 60-70%. For those with locally advanced unresectable TETs (LAU-TETs), some controversies about the prognostic factors and treatment modalities existed. The aims of this study are to elucidate the roles of various therapeutic options and to determine the survival and prognostic factors of LAU-TETs. Methods. Twenty-seven patients diagnosed with LAU-TETs underwent treatment in Taipei Veterans General Hospital between 1979 and 1997. Multiple treatment modalities, including surgical intervention, irradiation and chemotherapy, were advocated for these patients. The clinicopathological factors and the effects of the treatment modalities were evaluated retrospectively. Results. Twenty seven cases of LAU-TETs, included 18 thymomas (12 at stage III and 6 at stage IVa) and 9 thymic carcinomas (4 at stage III and 5 at stage IVa), were enrolled for study. The overall 5-year and 10-year survival rates were 54.6% and 35.1%, respectively. Patients receiving debulking surgery and those with irradiation dosage higher than 4400 cGy had significantly better survivals (P = 0.021 and P = 0.016, respectively). Conclusions. Aggressive debulking surgery and sufficient irradiation dosage provide better survivals for patients with LAU-TETs, especially for those with thymoma.

AB - Background. Surgery is the treatment of choice for thymic epithelial tumors (TET), but the resectability is about 60-70%. For those with locally advanced unresectable TETs (LAU-TETs), some controversies about the prognostic factors and treatment modalities existed. The aims of this study are to elucidate the roles of various therapeutic options and to determine the survival and prognostic factors of LAU-TETs. Methods. Twenty-seven patients diagnosed with LAU-TETs underwent treatment in Taipei Veterans General Hospital between 1979 and 1997. Multiple treatment modalities, including surgical intervention, irradiation and chemotherapy, were advocated for these patients. The clinicopathological factors and the effects of the treatment modalities were evaluated retrospectively. Results. Twenty seven cases of LAU-TETs, included 18 thymomas (12 at stage III and 6 at stage IVa) and 9 thymic carcinomas (4 at stage III and 5 at stage IVa), were enrolled for study. The overall 5-year and 10-year survival rates were 54.6% and 35.1%, respectively. Patients receiving debulking surgery and those with irradiation dosage higher than 4400 cGy had significantly better survivals (P = 0.021 and P = 0.016, respectively). Conclusions. Aggressive debulking surgery and sufficient irradiation dosage provide better survivals for patients with LAU-TETs, especially for those with thymoma.

KW - Chemotherapy

KW - Irradiation

KW - Surgery

KW - Thymic carcinoma

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=3042671036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042671036&partnerID=8YFLogxK

M3 - Article

C2 - 15244015

AN - SCOPUS:3042671036

VL - 67

SP - 172

EP - 178

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 4

ER -